Search Results - "Elmarjany, M."

  • Showing 1 - 11 results of 11
Refine Results
  1. 1

    Intramedullary spinal cord metastases: Report of three cases and review of the literature by Hommadi, M., Belemlih, M., Marnouch, E., Maghous, A., Zaghba, N., Hamidi, F.Z., Bazzine, A., Saghir, K.A., Elmarjany, M., Sifat, H., Hadadi, K., Mansouri, H.

    Published in Cancer radiothérapie (01-04-2021)
    “…Intramedullary spinal cord metastases (ISCM) is a rare, but devastating complication of malignant disease. Prognosis is poor, with an overall median survival…”
    Get full text
    Journal Article
  2. 2

    Evaluation of margins in pelvic lymph nodes and prostate radiotherapy and the impact of bladder and rectum on prostate position by Marnouche, E.A., Hadadi, K., Abdelhak, M., Benlemlih, M., Hommadi, M., Zaghba, N., Andaloussi Saghir, K., Elmarjany, M., Sifat, H., Mansouri, H.

    Published in Cancer radiothérapie (01-04-2021)
    “…The aims of this study were: determination of the CTV to PTV margins for prostate and pelvic lymph nodes. Investigation of the impact of registration modality…”
    Get full text
    Journal Article
  3. 3

    RapidArc for centrally recurrent cervical cancer in the vaginal cuff following primary surgical therapy: a case report by Lalya, I, Maghous, A, Marnouche, E, Zaghba, N, Andaloussi, K, Elmarjany, M, Hadadi, K, Sifat, H, Mansouri, H

    Published in World journal of surgical oncology (22-01-2016)
    “…Pelvic recurrences of cervical cancer after primary surgical treatment can be potentially cured with radical hysterectomy or chemoradiation therapy. Combined…”
    Get full text
    Journal Article
  4. 4

    Combined radiation therapy and androgen deprivation in the management of prostate cancer: Where do we stand? by Bellefqih, S, Hadadi, K, Mezouri, I, Maghous, A, Marnouche, E, Andaloussi, K, Elmarjany, M, Sifat, H, Mansouri, H, Benjaafar, N

    Published in Cancer radiothérapie (01-04-2016)
    “…Radiotherapy and androgen deprivation therapy play a major role in the management of prostate cancer. Indeed, radiotherapy and hormone therapy are combined in…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    Addressing the Arguments Against Omitting Radiotherapy After Breast-Conserving Surgery for Early Luminal Breast Cancers by Maghous, A., Lalya, I., Marnouche, E., Hommadi, M., Belemlih, M., Andaloussi Saghir, K., Elmarjany, M., Hadadi, K., Sifat, H.

    Published in Indian journal of gynecologic oncology (01-12-2024)
    “…While luminal A breast cancer often has a favorable prognosis, omitting radiotherapy (RT) after breast-conserving surgery (BCS) remains a controversial…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Association de radiothérapie et d’hormonothérapie dans la prise en charge des cancers localisés de la prostate : où en est-on ? by Bellefqih, S., Hadadi, K., Mezouri, I., Maghous, A., Marnouche, E., Andaloussi, K., Elmarjany, M., Sifat, H., Mansouri, H., Benjaafar, N.

    Published in Cancer radiothérapie (01-04-2016)
    “…La radiothérapie et l’hormonothérapie occupent une place essentielle dans l’arsenal thérapeutique des cancers de la prostate. En effet, radiothérapie et…”
    Get full text
    Journal Article
  10. 10
  11. 11